Voyager Therapeutics (VYGR) Reports Q2 Loss, Lags Revenue Estimates

Voyager Therapeutics (VYGR) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares to a loss of $0.18 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -18.75%. A quarter ago, it was expected that this gene therapy company would post a loss of $0.35 per share when it actually produced a loss of $0.53, delivering a surprise of -51.43%.Over the last four quarters, th ...